Nanobodies against SARS-CoV-2 reduced virus load in the brain of challenged mice and neutralized Wuhan, Delta and Omicron Variants
M. F. Pavan, M. Bok, R. Betanzos San Juan, J. P. Malito, G. A. Marcoppido, D. R. Franco, D. A. Militello, J. M. Schammas, S. Bari, W. B. Stone, K. Lopez, D. Porier, J. Muller, A. J. Auguste, L. Yuan, , L. I. Ibanez
This study develops nanobodies against SARS-CoV-2 that neutralize multiple variants and reduce viral load in the brain of infected mice.
bioRxiv · Mar 14, 2023 · PreprintImmunology